Dr. Zengqing Guo 郭增清
Chief Physician
Department of Medical Oncology for Abdominal Tumors, Fujian Cancer Hospital, Fuzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Medical oncology for digestive tract tumors, including gastric, colorectal, and liver cancer. Focuses on chemotherapy and internal medicine management.
Dr. Guo is Chief Physician and Administrative Director of Ward 8. Graduated from Fujian Medical University in 1991. Completed one year of advanced training at Sun Yat-sen University Cancer Center in 1999. Has published multiple papers in provincial-level or higher journals.
Professional roles
- Member, Rehabilitation and Palliative Care Professional Committee, Fujian Anti-Cancer Association
Name order: in Chinese the family name comes first (Guo Zengqing). Papers usually list the name as Zengqing Guo or Guo Z.
Selected publications
93 papers on PubMed matched by name and affiliation; 10 as first or senior author since 2016. Most recent first- or senior-author papers:
- Cancer Causes Control, 2026 (senior author): Trends and burden of colon and rectum cancer attributable to low physical activity in China: a comprehensive analysis from 1990 to 2021. PubMed 42525305
- Front Immunol, 2026 (senior author): Identification of plasma lipidomic biomarkers for prognostic stratification in advanced gastric cancer treated with PD-1 inhibitor plus chemotherapy. PubMed 41737223
- Ann Surg Oncol, 2025 (senior author): ASO Author Reflections: Addressing the Rising Burden of Colon and Rectum Cancer in China: Gender Disparities, Trends, and Projections. PubMed 39873849
- Ann Surg Oncol, 2025 (senior author): Rising Burden of Colon and Rectum Cancer in China: An Analysis of Trends, Gender Disparities, and Projections to 2030. PubMed 39836276
- Sci Rep, 2025 (senior author): Long-term trends and future projections of liver cancer burden in China from 1990 to 2030. PubMed 40240432
- Front Immunol, 2025 (senior author): Neoadjuvant chemotherapy combined with antiangiogenic therapy and immune checkpoint inhibitors for the treatment of locally advanced gastric cancer: a real - world retrospective cohort study. PubMed 39967656
- Front Oncol, 2022 (senior author): IL-6, TNF-α and IL-12p70 levels in patients with colorectal cancer and their predictive value in anti-vascular therapy. PubMed 36226059
- NPJ Precis Oncol, 2022 (first author): Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer. PubMed 35661819
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion